COVID-19 Doesn't Worsen Multiple Sclerosis, Study Says
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
FRIDAY, Dec. 27, 2024 -- People with multiple sclerosis (MS) have been concerned that a COVID-19 infection could cause the symptoms of their nerve disease to become even worse.
But a new study should offer some solace -- COVID doesn’t appear to worsen MS, researchers reported Dec. 23, 2024 in the journal Neurology.
“Infections may be associated with more disability among people with MS,” researcher Amber Salter, an associate professor of biostatistics with UT Southwestern Medical Center in Dallas, Texas, said in a news release from the American Academy of Neurology. “However, our study found that for COVID-19 infections specifically, this was not true.”
“This is good news for people with MS, that they do not need to worry about long-term worsening of their MS symptoms after a COVID-19 infection,” Salter added.
Earlier studies indicated that COVID infection might cause MS symptoms to worsen, particularly if the symptoms coincide with those associated with long COVID.
For this new study, researchers tracked more than 2,100 MS patients for more than 18 months. About 37% of the patients had been infected with COVID.
Patients reported the severity of their MS symptoms at least six times during the study. These symptoms can include muscle weakness, changes to vision, and numbness.
The patients were also asked about other symptoms like walking ability, hand function, body pain, fatigue, and problems with memory and thinking.
Results showed no significant differences in MS symptoms between people who’d been infected with COVID and those who hadn’t.
COVID infection also didn’t cause greater disability among MS patients, researchers said.
“Our study indicates that COVID-19 infection was not associated with immediate changes in symptom severity or disability, nor did it change the MS symptoms or disability trajectory for more than a year and a half after the infection,” Salter said.
However, researchers noted that this study focused on older MS patients with an average age of 65.
“While our study looked primarily at older people and results may not be the same for younger people, these findings help us better understand how this type of infection can affect people with MS,” Salter concluded.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-22 06:00
Read more
- Teen Stress Is Expensive, Experts Say -- So How Can We Reduce It?
- FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
- Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
- Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation
- FDA: Listeria Concerns Prompt Broccoli Recall at Walmart Stores
- Can Carrots Help Treat Type 2 Diabetes?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions